Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 3
1982 3
1983 4
1984 15
1985 7
1986 4
1987 1
1988 1
1989 4
1990 2
1991 5
1992 3
1993 6
1994 5
1995 10
1996 9
1997 6
1998 5
1999 7
2000 2
2001 9
2002 11
2003 8
2004 3
2005 8
2006 8
2007 6
2008 9
2009 6
2010 7
2011 13
2012 8
2013 6
2014 4
2015 6
2016 5
2017 6
2018 1
2019 3
2020 7
2021 8
2022 9
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

240 results

Results by year

Filters applied: . Clear all
Page 1
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.
Kim YH, Bagot M, Pinter-Brown L, Rook AH, Porcu P, Horwitz SM, Whittaker S, Tokura Y, Vermeer M, Zinzani PL, Sokol L, Morris S, Kim EJ, Ortiz-Romero PL, Eradat H, Scarisbrick J, Tsianakas A, Elmets C, Dalle S, Fisher DC, Halwani A, Poligone B, Greer J, Fierro MT, Khot A, Moskowitz AJ, Musiek A, Shustov A, Pro B, Geskin LJ, Dwyer K, Moriya J, Leoni M, Humphrey JS, Hudgens S, Grebennik DO, Tobinai K, Duvic M; MAVORIC Investigators. Kim YH, et al. Among authors: rook ah. Lancet Oncol. 2018 Sep;19(9):1192-1204. doi: 10.1016/S1470-2045(18)30379-6. Epub 2018 Aug 9. Lancet Oncol. 2018. PMID: 30100375 Free article. Clinical Trial.
Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma.
Watanabe K, Gomez AM, Kuramitsu S, Siurala M, Da T, Agarwal S, Song D, Scholler J, Rotolo A, Posey AD, Rook AH, Haun PL, Ruella M, Young RM, June CH. Watanabe K, et al. Among authors: rook ah. Blood Adv. 2023 Jul 25;7(14):3416-3430. doi: 10.1182/bloodadvances.2022008327. Blood Adv. 2023. PMID: 37058474 Free PMC article.
Immunobiology and treatment of cutaneous T-cell lymphoma.
Goel RR, Rook AH. Goel RR, et al. Among authors: rook ah. Expert Rev Clin Immunol. 2024 Mar 7:1-12. doi: 10.1080/1744666X.2024.2326035. Online ahead of print. Expert Rev Clin Immunol. 2024. PMID: 38450476 Review.
Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management.
Musiek ACM, Rieger KE, Bagot M, Choi JN, Fisher DC, Guitart J, Haun PL, Horwitz SM, Huen AO, Kwong BY, Lacouture ME, Noor SJ, Rook AH, Seminario-Vidal L, Vermeer MH, Kim YH. Musiek ACM, et al. Among authors: rook ah. Dermatol Ther (Heidelb). 2022 Jan;12(1):29-40. doi: 10.1007/s13555-021-00624-7. Epub 2021 Nov 23. Dermatol Ther (Heidelb). 2022. PMID: 34816383 Free PMC article. Review.
Extracorporeal photopheresis: past, present, and future.
Knobler R, Barr ML, Couriel DR, Ferrara JL, French LE, Jaksch P, Reinisch W, Rook AH, Schwarz T, Greinix H. Knobler R, et al. Among authors: rook ah. J Am Acad Dermatol. 2009 Oct;61(4):652-65. doi: 10.1016/j.jaad.2009.02.039. Epub 2009 Aug 7. J Am Acad Dermatol. 2009. PMID: 19665258 Review.
Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial.
Kim EJ, Mangold AR, DeSimone JA, Wong HK, Seminario-Vidal L, Guitart J, Appel J, Geskin L, Lain E, Korman NJ, Zeitouni N, Nikbakht N, Dawes K, Akilov O, Carter J, Shinohara M, Kuzel TM, Piette W, Bhatia N, Musiek A, Pariser D, Kim YH, Elston D, Boh E, Duvic M, Huen A, Pacheco T, Zwerner JP, Lee ST, Girardi M, Querfeld C, Bohjanen K, Olsen E, Wood GS, Rumage A, Donini O, Haulenbeek A, Schaber CJ, Straube R, Pullion C, Rook AH, Poligone B. Kim EJ, et al. Among authors: rook ah. JAMA Dermatol. 2022 Sep 1;158(9):1031-1039. doi: 10.1001/jamadermatol.2022.2749. JAMA Dermatol. 2022. PMID: 35857290 Free PMC article. Clinical Trial.
Update on treatment of cutaneous T-cell lymphoma.
Gardner JM, Evans KG, Musiek A, Rook AH, Kim EJ. Gardner JM, et al. Among authors: rook ah. Curr Opin Oncol. 2009 Mar;21(2):131-7. doi: 10.1097/CCO.0b013e3283253190. Curr Opin Oncol. 2009. PMID: 19532014 Review.
240 results